Inventor · disambiguated record
Alan Collis
Also filed as: COLLIS ALAN · COLLIS ALAN J · COLLIS ALAN JOHN
22 granted patents·7 pending applications·241 citations·filing 1991–2024
95Inventor score
Files withFORMA THERAPEUTICS INC11PFIZER6AVENTIS PHARMA LTD4TAKEDA PHARMACEUTICALS CO3CHOI-SLEDESKI YONG MI2
Top patents by PatentIndex Score
29 records- 0195US11497743B2Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutationFORMA THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·3 cites·22 claims
- 0292US6479519B1Substituted anilidesAVENTIS PHARMA LTD·Filed 2000·Granted Nov 12, 2002·72 cites·81 claims
- 0391US11963956B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·1 cites·20 claims
- 0491US6649620B2Quinoline and quinazoline compounds useful in therapyPFIZER·Filed 2002·Granted Nov 18, 2003·26 cites·8 claims
- 0591US6642242B2Quinoline and quinazoline compounds useful in therapyPFIZER·Filed 2001·Granted Nov 4, 2003·46 cites·9 claims
- 0689US6417194B1Quinolines and quinazolines useful in therapyPFIZER·Filed 2000·Granted Jul 9, 2002·34 cites·7 claims
- 0788US11738018B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·1 cites·20 claims
- 0884US11311527B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2020·Granted Apr 26, 2022·1 cites·19 claims
- 0984US11013734B2Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutationFORMA THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·1 cites·24 claims
- 1082US11576906B2Inhibiting mutant IDH-1FORMA THERAPEUTICS INC·Filed 2019·Granted Feb 14, 2023·1 cites·3 claims
- 1180US2024148718A1INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1278US11013733B2Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)FORMA THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·1 cites·21 claims
- 1377US2025082628A1INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1476US11376246B2Inhibiting mutant IDH-1FORMA THERAPEUTICS INC·Filed 2019·Granted Jul 5, 2022·1 cites·10 claims
- 1574US6750214B2Quinoline and quinazoline compounds useful in therapyFiled 2003·Granted Jun 15, 2004·7 cites·8 claims
- 1663US2025215002A1Solid forms of tyk2 inhibitors and methods of useTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1762US6989395B2Imidazolyl-cyclic acetalsAVENTIS PHARMA LTD·Filed 2003·Granted Jan 24, 2006·1 cites·27 claims
- 1862US2025213572A1Tyk2 inhibitors and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1961US7479501B2Heteroaryl-cyclic acetalsAVENTIS PHARMA LTD·Filed 2001·Granted Jan 20, 2009·1 cites·5 claims
- 2061US2023101121A1Treating patients harboring an isocitrate dehydrogenase-1 (idh-1) mutationFORMA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2159US6602877B1Imidazolyl-cyclic acetalsAVENTIS PHARMA LTD·Filed 1999·Granted Aug 5, 2003·15 cites·36 claims
- 2259US2025221997A1Tyk2 inhibitor formulations and methods of making the sameTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2356US6103738AQuinoline and quinazoline compounds useful in therapyPFIZER·Filed 1996·Granted Aug 15, 2000·11 cites·13 claims
- 2456US6048864AQuinolines and quinazolines useful in therapyPFIZER·Filed 1998·Granted Apr 11, 2000·5 cites·6 claims
- 2555US8183231B2Substituted propane phosphinic acid derivativesCHOI-SLEDESKI YONG MI·Filed 2006·Granted May 22, 2012·0 cites·34 claims
- 2648US8828974B2Substituted propane phosphinic acid derivativesCHOI-SLEDESKI YONG MI·Filed 2012·Granted Sep 9, 2014·0 cites·20 claims
- 2748US7687540B2Substituted propane phosphinic acid estersAVENTIS PHARMA INC·Filed 2007·Granted Mar 30, 2010·0 cites·13 claims
- 2848US2004034032A1Quinoline and quinazoline compounds useful in therapyPFIZER·Filed 2003·Application pending·0 cites
- 2945US5108121ABoat trailer extension armCOLLIS ALAN·Filed 1991·Granted Apr 28, 1992·13 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →